GENSCRIPT BIOTECH CORPORATION financial statements, including revenue, expenses, profit, and loss
The total revenue of 1548 for the last semiannual is 3.50 B HKD, and it's 14.26% higher compared to the previous semiannual. The net income of H2 23 is -14.83 M HKD.